๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-08-06

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer (NCT07741968)

๐ŸŸข Recruiting Observational / Diagnostic ๐Ÿง  Behavioral & Psychological Program Sponsor: City of Hope Medical Center

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

This clinical trial studies whether an intervention supported by technology (blended e-health intervention) works to improve fear of progression (FOP) in women with gynecologic or breast cancer. FOP is the fear patients experience from the possibility that their cancer could grow, spread, or get worse. Managing FOP is a leading unmet concern of cancer patients. High levels of FOP are associated with distress, depression, and increased health care costs, despite this, access to resources to address FOP remain limited. The blended e-health intervention in this trial offers remote group sessions along with online sessions to help patients access the information. Session content incorporates values-based goal setting and skills practices to manage unhelpful beliefs about worry and promote helpful coping behaviors. The sessions may help patients recognize unhelpful thoughts and behaviors which reinforce worry. A blended e-health intervention may be an effective way to improve FOP in women with gynecologic or breast cancer.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (4 items) and avoid the listed exclusions (6 items).

Location: City of Hope at Arcadia โ€” Arcadia, California

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Usually NOT eligible if any of the following apply:

  • Exclusion Criteria:
  • Enrolled in hospice
  • Ongoing uncontrolled active psychiatric condition that, in the opinion of the investigator, would interfere in the conduct of the study (e.g., mood disorders, psychosis disorders, or substance use), Major depression as assessed by Patient Health Questionnaire-9 (PHQ-9)
  • Non-English speaking
  • Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)
  • Current participation in a mind-body or mindfulness education program within the past six weeks

๐Ÿ” Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

๐Ÿ“ All Participating Trial Locations (11 Sites)

  • City of Hope at Arcadia โ€” Arcadia, California
  • City of Hope Medical Center โ€” Duarte, California
  • City of Hope at Seacliff โ€” Huntington Beach, California
  • City of Hope at Irvine Lennar โ€” Irvine, California
  • City of Hope Antelope Valley โ€” Lancaster, California
  • City of Hope at Long Beach Elm โ€” Long Beach, California
  • City of Hope at Santa Clarita โ€” Santa Clarita, California
  • City of Hope at Simi Valley โ€” Simi Valley, California
  • City of Hope at South Pasadena โ€” South Pasadena, California
  • City of Hope at Upland โ€” Upland, California
  • City of Hope at West Covina โ€” West Covina, California

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
๐Ÿ›๏ธ View Official NIH Record โ†—